Sanofi-Aventis Merger Set; $65 Bil. Deal Means More Leverage With Managed Care

Sanofi-Aventis' $30 bil. pharma/vaccine business will provide bulk necessary to better negotiate discounts. Sanofi has not had much opportunity to work within U.S. managed care system, but says it will learn from Aventis.